Movement Alert|Hansoh Pharmaceutical Declines 3.33% in Regular Trading, Trading at HK$31.98

Market Focus07-21

On July 21, Hansoh Pharmaceutical declined 3.33% in regular trading, trading at HK$31.98/share, with turnover of HK$71.85 million.

Within the Pharmaceuticals sector where Hansoh Pharmaceutical belongs, the overall sector trended lower. Among individual stocks, CSPC Pharma down 2.0%, SBP Group down 2.32%, Hengrui Pharma down 4.0%, Asymchem down 0.08%, Simcere Pharma down 0.46%.

Hansoh Pharmaceutical Group Co., Ltd. is a China-based investment holding company principally engaged in the research and development, manufacturing, and sale of pharmaceutical products. Its innovative drug portfolio covers anti-tumor, anti-infection, central nervous system diseases, metabolic diseases, and other therapeutic areas.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment